06:09 EDT Immuneering (IMRX) files to sell 9.18M shares of Class A common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMRX:
- Immuneering’s Strategic Partnerships and Promising Clinical Developments Justify Buy Rating
- Immuneering announces clinical supply agreement with Eli Lilly
- Immuneering prices 6.3M shares at $3.95 in private placement
- Immuneering Corp. Reports Strong Trial Results and Patent Win
- Immuneering files $300M mixed securities shelf